1. Baba, M., Mori, S., Shigeta, S. and De Clercq, E. (1987) Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2′-nor-cyclic GMP on adenovirus replication in vitro. Antimicrob. Agents Chemother. 31, 337–339.
2. Balzarini, J., Baba, M., Pauwels, R., Herdewijn, P., Wood, S.G., Robins, M.J. and DeClercq, E. (1988) Potent and selective activity of 3′-azido-2,6-diaminopurine-2′,3′-dideoxyriboside, 3′-fluoro-2,6-diaminopurine-2′,3′-dideoxyriboside, and 3′-fluoro-2′,3′-dideoxyguanosine against human immunodeficiency virus. Mol. Pharmacol. 33, 243–249.
3. Chu, C.K.V., Bhadti, S., Doboszewski, B., Gu, Z.G., Kosugi, Y., Pullaiah, K.C. and van Roey, P. (1989) General synthesis of 2′,3′-dideoxynucleosides and 2′,3′-didehydro-2′,3′-dideoxynucleosides. J. Org. Chem. 54, 2217–2225.
4. Cotton, M. and Weber, J.M. (1995) The adenovirus protease is required for virus entry into host cells. Virology 213, 494–502.
5. De Clercq, E. (1990) Selective virus inhibitors. Microbiologica 13, 165–178.